- Home
- GNFT vs SCWO Comparison
GNFT vs SCWO Comparison
Compare GNFT & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- SCWO
- Stock Information
- Founded
- GNFT 1999
- SCWO 2021
- Country
- GNFT France
- SCWO United States
- Employees
- GNFT N/A
- SCWO 26
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- SCWO Environmental Services
- Sector
- GNFT Health Care
- SCWO Utilities
- Exchange
- GNFT Nasdaq
- SCWO Nasdaq
- Market Cap
- GNFT 179.7M
- SCWO 64.3M
- IPO Year
- GNFT 2019
- SCWO N/A
- Fundamental
- Price
- GNFT $3.91
- SCWO $0.42
- Analyst Decision
- GNFT Strong Buy
- SCWO
- Analyst Count
- GNFT 1
- SCWO 0
- Target Price
- GNFT $13.00
- SCWO N/A
- AVG Volume (30 Days)
- GNFT 9.9K
- SCWO 405.6K
- Earning Date
- GNFT 09-19-2024
- SCWO 03-28-2025
- Dividend Yield
- GNFT N/A
- SCWO N/A
- EPS Growth
- GNFT N/A
- SCWO N/A
- EPS
- GNFT 0.47
- SCWO N/A
- Revenue
- GNFT $86,225,222.00
- SCWO $313,930.00
- Revenue This Year
- GNFT $145.20
- SCWO N/A
- Revenue Next Year
- GNFT N/A
- SCWO $5,180.00
- P/E Ratio
- GNFT $7.89
- SCWO N/A
- Revenue Growth
- GNFT 175.45
- SCWO N/A
- 52 Week Low
- GNFT $3.35
- SCWO $0.44
- 52 Week High
- GNFT $6.42
- SCWO $1.99
- Technical
- Relative Strength Index (RSI)
- GNFT 54.95
- SCWO 23.95
- Support Level
- GNFT $3.68
- SCWO $0.54
- Resistance Level
- GNFT $3.96
- SCWO $0.58
- Average True Range (ATR)
- GNFT 0.13
- SCWO 0.06
- MACD
- GNFT 0.05
- SCWO -0.00
- Stochastic Oscillator
- GNFT 79.49
- SCWO 0.55
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The business activities of the company include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.